Beyondspring Inc - ESG Rating & Company Profile powered by AI
Other corporations in the scoring industry group for Beyondspring Inc are shownin the table. This Sustainability score for Beyondspring Inc represents its reporting of the United Nations Sustainable Development Goals. The Disclosure score covers seventeen United Nations SDGs including: 'No Poverty', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'.
Beyondspring Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.3; made up of an environmental score of 6.4, social score of 6.4 and governance score of 5.3.
6.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 535 | aTyr Pharma Inc | 6.4 | High |
| 535 | Verastem Inc | 6.4 | High |
| 563 | Beyondspring Inc | 6.3 | High |
| 563 | Acasti Pharma Inc | 6.3 | High |
| 563 | Adamas Pharmaceuticals Inc | 6.3 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Beyondspring Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Beyondspring Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Beyondspring Inc report the average age of the workforce?
Sign up for free to unlockDoes Beyondspring Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Beyondspring Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Beyondspring Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Beyondspring Inc offer flexible work?
Sign up for free to unlockDoes Beyondspring Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Beyondspring Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Beyondspring Inc conduct supply chain audits?
Sign up for free to unlockDoes Beyondspring Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Beyondspring Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Beyondspring Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Beyondspring Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Beyondspring Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Beyondspring Inc disclose water use targets?
Sign up for free to unlockDoes Beyondspring Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Beyondspring Inc have a product recall in the last two years?
Sign up for free to unlockDoes Beyondspring Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Beyondspring Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Beyondspring Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Beyondspring Inc disclose parental leave metrics?
Sign up for free to unlockDoes Beyondspring Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Beyondspring Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Beyondspring Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Beyondspring Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Beyondspring Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Beyondspring Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Beyondspring Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Beyondspring Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Beyondspring Inc disclose its waste policy?
Sign up for free to unlockDoes Beyondspring Inc report according to TCFD requirements?
Sign up for free to unlockDoes Beyondspring Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Beyondspring Inc disclose energy use targets?
Sign up for free to unlockDoes Beyondspring Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Beyondspring Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Beyondspring Inc
These potential risks are based on the size, segment and geographies of the company.
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.